About NT PHARMA Company

China Tailing Pharmaceutical Group was founded in 1995. It is a comprehensive pharmaceutical group mainly engaged in investment research, development, production, marketing and promotion of new pharmaceuticals and medical technology. On April 20, 2011, the Group was listed on the main board of the Hong Kong Stock Exchange (stock code: 01011.HK). The group is headquartered in Hong Kong, China. It has set up an investment and marketing management headquarters in Shanghai, a research and development company in Beijing, and has dozens of R&D, pharmaceutical and sales companies across the country, in Hong Kong, Shanghai, Jiangsu, Beijing, Guangzhou, Changsha, Hainan, etc. The Group focuses on developing core products under its own brand, covering various treatment fields such as tumors and hematological diseases, digestive diseases, central nervous system diseases, respiratory diseases, etc. There are 131 product registration numbers approved by the China Food and Drug Administration. Of these, more than 20 products are being manufactured and sold in pharmaceutical companies under the Group.